Firefly Neuroscience Inc (AIFF)

Apr 13, 2026, 7:45 AM EDT - 4 weeks ago

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository

2026-03-26T11:50:21.000Z - 6 weeks ago

Firefly enters Department of War partnership for PTSD, TBI treatment

Mar 26, 2026, 7:45 AM EDT - 6 weeks ago

Firefly Confirms Public-Private Partnership with the Department of War

2026-03-13T12:01:50.000Z - 2 months ago

Firefly says EEG/ERP technology may help identify ADHD subtypes

Mar 13, 2026, 7:55 AM EDT - 2 months ago

Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD

2026-03-04T12:47:59.000Z - 2 months ago

Firefly Neuroscience announces 20-fold expansion of commercial footprint

Mar 4, 2026, 7:45 AM EST - 2 months ago

Firefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration

2025-12-03T22:05:37.000Z - 5 months ago

Firefly Neuroscience files $250M mixed securities shelf

2025-11-12T12:51:04.000Z - 6 months ago

Firefly Neuroscience reports Q3 EPS (20c) vs. (61c) last year

Nov 12, 2025, 7:45 AM EST - 6 months ago

Firefly Neuroscience Reports Third Quarter 2025 Financial Results

2025-09-05T12:00:56.000Z - 8 months ago

Firefly Neuroscience partners with HealingMaps for electrophysiology analytics

Sep 5, 2025, 7:55 AM EDT - 8 months ago

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

2025-08-26T11:50:26.000Z - 9 months ago

Firefly Neuroscience unveils new CLEAR Platform

NVDA

Aug 26, 2025, 7:45 AM EDT - 9 months ago

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

2025-07-18T10:17:43.000Z - 10 months ago

Firefly Neuroscience files to sell 6M shares of common stock for holders

2025-07-14T11:51:03.000Z - 10 months ago

Firefly Neuroscience enter commercial agreement for use of BNA platform

Jul 14, 2025, 7:45 AM EDT - 10 months ago

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

2025-06-23T17:59:22.000Z - 11 months ago

Firefly Neuroscience to be added to Russell Microcap Index

Jun 23, 2025, 8:05 AM EDT - 11 months ago

Firefly Neuroscience to be Added to the Russell Microcap® Index

2025-06-20T11:50:14.000Z - 11 months ago

Firefly uncovers way of measuring SCD, MCI, dementia in Alzheimer’s patients

Jun 20, 2025, 7:45 AM EDT - 11 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

May 5, 2025, 9:00 PM EDT - 1 year ago

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

2025-05-05T11:51:43.000Z - 1 year ago

Firefly Neuroscience announces acquisition of Evoke Neuroscience

May 5, 2025, 7:45 AM EDT - 1 year ago

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Mar 6, 2025, 7:30 AM EST - 1 year ago

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

2025-02-21T13:15:55.000Z - 1 year ago

Firefly Neuroscience announces exercise of warrants for $8.8M

Feb 21, 2025, 8:00 AM EST - 1 year ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

2025-02-13T16:43:44.000Z - 1 year ago

Firefly Neuroscience Inc trading resumes

2025-02-13T16:35:47.000Z - 1 year ago

Firefly Neuroscience Inc trading halted, volatility trading pause

Feb 11, 2025, 7:45 AM EST - 1 year ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 7, 2025, 7:30 AM EST - 1 year ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Jan 14, 2025, 7:45 AM EST - 1 year ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Dec 31, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Nov 14, 2024, 5:30 PM EST - 1 year ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 6, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Oct 25, 2024, 4:10 PM EDT - 1 year ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 16, 2024, 9:20 AM EDT - 1 year ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Sep 10, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Aug 26, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 21, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 13, 2024, 4:06 PM EDT - 1 year ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq